Status under the Securities Act. The Company was not and is not an ineligible issuer as defined in Rule 405 under the Securities Act at the times specified in Rules 164 and 433 under the Securities Act in connection with the offering of the Placement Shares.
Appears in 593 contracts
Samples: Sales Agreement (Quince Therapeutics, Inc.), Sales Agreement (Mawson Infrastructure Group Inc.), Sales Agreement (Hut 8 Corp.)
Status under the Securities Act. The Company was not and is not an ineligible issuer as defined in Rule 405 under the Securities Act at the times specified in Rules 164 and 433 under the Securities Act in connection with the offering of the Placement Shares.
Appears in 68 contracts
Samples: Sales Agreement (CorMedix Inc.), At Market Issuance Sales Agreement (Ra Medical Systems, Inc.), At Market Issuance Sales Agreement (Forte Biosciences, Inc.)
Status under the Securities Act. The Company was not and is not an ineligible issuer as defined in Rule 405 under the Securities Act at the times specified in Rules 164 and 433 under the Securities Act in connection with the offering of the Placement Shares.
Appears in 27 contracts
Samples: At Market Issuance Sales Agreement (Xoma LTD /De/), Sales Agreement (Magnum Hunter Resources Corp), At Market Issuance Sales Agreement (Peregrine Pharmaceuticals Inc)
Status under the Securities Act. The Company was not and is not an ineligible issuer as defined in Rule 405 under the Securities Act at the times specified in Rules 164 and 433 under the Securities Act in connection with the offering of the Placement Shares.
Appears in 25 contracts
Samples: Open Market Sale Agreement (Achieve Life Sciences, Inc.), At the Market Sales Agreement (Mediaco Holding Inc.), At Market Issuance Sales Agreement (Perspective Therapeutics, Inc.)
Status under the Securities Act. The Company was not and is not an ineligible issuer as defined in Rule 405 under the Securities Act at the times specified in Rules 164 and 433 under the Securities Act in connection with the offering of the Placement Shares.
Appears in 20 contracts
Samples: Capital on Demand Sales Agreement (IDI, Inc.), At the Market Issuance Sales Agreement (RAIT Financial Trust), At Market Issuance Sales Agreement (GreenHunter Energy, Inc.)
Status under the Securities Act. The Company was not and is not an “ineligible issuer issuer” as defined in Rule 405 under the Securities Act at the times specified in Rules 164 and 433 under the Securities Act in connection with the offering of the Placement SharesUnits.
Appears in 10 contracts
Samples: Underwriting Agreement (Draganfly Inc.), Underwriting Agreement (Draganfly Inc.), Underwriting Agreement (Vista Gold Corp)
Status under the Securities Act. The Company was not and is not an “ineligible issuer issuer” as defined in Rule 405 under the Securities Act at the times specified in Rules 164 and 433 under the Securities Act in connection with the offering of the Placement Shares.
Appears in 10 contracts
Samples: Sales Agreement (Caledonia Mining Corp PLC), Sales Agreement (Caledonia Mining Corp PLC), At Market Issuance Sales Agreement (Peabody Energy Corp)
Status under the Securities Act. The Company was not and is not an “ineligible issuer issuer” as defined in Rule 405 under the Securities Act at the times specified in Rules 164 and 433 under the Securities Act in connection with the offering of the Placement Offered Shares.
Appears in 10 contracts
Samples: Underwriting Agreement (Western Copper & Gold Corp), Underwriting Agreement (Denison Mines Corp.), Underwriting Agreement (Western Copper & Gold Corp)
Status under the Securities Act. The Company was not and is not an ineligible issuer as defined in Rule 405 under of the Securities Act Regulations at the times specified in Rules 164 and 433 under of the Securities Act Regulations in connection with the offering of the Placement Shares.
Appears in 8 contracts
Samples: At Market Issuance Sales Agreement (Stellus Capital Investment Corp), At Market Issuance Sales Agreement (Stellus Capital Investment Corp), At Market Issuance Sales Agreement (MONROE CAPITAL Corp)
Status under the Securities Act. The Company was not and is not an "ineligible issuer issuer" as defined in Rule 405 under the Securities Act at the times specified in Rules 164 and 433 under the Securities Act in connection with the offering of the Placement Offered Shares.
Appears in 6 contracts
Samples: Underwriting Agreement (Taseko Mines LTD), Underwriting Agreement (Northern Dynasty Minerals LTD), Underwriting Agreement (Northern Dynasty Minerals LTD)
Status under the Securities Act. The Company was not and is not an ineligible issuer as defined in Rule 405 under the Securities Act at the times specified in Rules 164 and 433 under the Securities Act in connection with the offering of the Placement Shares.
Appears in 5 contracts
Samples: Sales Agreement (Chemomab Therapeutics Ltd.), At Market Issuance Sales Agreement (Piedmont Lithium Inc.), At Market Issuance Sales Agreement (Troika Media Group, Inc.)
Status under the Securities Act. The Company was not and is not an ineligible issuer as defined in Rule 405 under the Securities Act at the times specified in Rules 164 and 433 under the Securities Act in connection with the offering of the Placement SharesADSs.
Appears in 5 contracts
Samples: Sales Agreement (Alterity Therapeutics LTD), At Market Issuance Sales Agreement (Sequans Communications), At Market Issuance Sales Agreement (Prana Biotechnology LTD)
Status under the Securities Act. The Company was not and is not an ineligible issuer as defined in Rule 405 under the Securities Act at the times specified in Rules 164 and 433 under the Securities Act in connection with the offering of any of the Placement Shares.
Appears in 4 contracts
Samples: At Market Issuance Sales Agreement (Soligenix, Inc.), Sales Agreement (Applied Digital Corp.), Sales Agreement (Applied Digital Corp.)
Status under the Securities Act. The Company was not and is not an ineligible issuer as defined in Rule 405 under the Securities Act at the times specified in Rules 164 and 433 under the Securities Act in connection with the offering of the Placement SharesSecurities.
Appears in 4 contracts
Samples: Securities Purchase Agreement (Gorilla Technology Group Inc.), Underwriting Agreement (Novus Therapeutics, Inc.), Placement Agency Agreement (Compugen LTD)
Status under the Securities Act. The Company was not and is not an ineligible issuer as defined in Rule 405 under the Securities Act at the times specified in Rules 164 and 433 under the Securities Act in connection with the offering of the Placement SharesStock.
Appears in 4 contracts
Samples: Underwriting Agreement (Aspen Aerogels Inc), Underwriting Agreement (Aerie Pharmaceuticals Inc), Underwriting Agreement (Aerie Pharmaceuticals Inc)
Status under the Securities Act. The Company was not and is not an ineligible issuer as defined in Rule 405 under the Securities Act at the times specified in Rules 164 and 433 under the Securities Act in connection with the offering of the Placement Offered Shares.
Appears in 3 contracts
Samples: Underwriting Agreement (Ocugen, Inc.), Underwriting Agreement (Cryoport, Inc.), Underwriting Agreement (Cellular Biomedicine Group, Inc.)
Status under the Securities Act. The Company was not and is not an ineligible issuer as defined in Rule 405 under the Securities Act at the times specified in Rules 164 and 433 under the Securities Act in connection with the offering of the Placement SharesADSs.
Appears in 2 contracts
Samples: Sales Agreement (Gracell Biotechnologies Inc.), Sales Agreement (BICYCLE THERAPEUTICS PLC)
Status under the Securities Act. The Company was not and is not an ineligible issuer as defined in under Rule 405 under the Securities Act Act, or otherwise satisfies the eligibility requirements set forth under and at the times specified in Rules 164 and 433 under the Securities Act in connection with the offering of the Placement Shares.
Appears in 2 contracts
Samples: At the Market Issuance Sales Agreement (Evolution Petroleum Corp), At the Market Issuance Sales Agreement (GMX Resources Inc)
Status under the Securities Act. The Company was not and is not an ineligible issuer as defined in Rule 405 under the Securities Act at the times specified in Rules 164 and 433 under the Securities Act in connection with the offering of the Placement Shares.
Appears in 2 contracts
Samples: At Market Issuance Sales Agreement (Meta Materials Inc.), Underwriting Agreement (Forte Biosciences, Inc.)
Status under the Securities Act. The Company was not and is not an "ineligible issuer issuer" as defined in Rule 405 under the Securities Act at the times specified in Rules 164 and 433 under the Securities Act in connection with the offering of the Placement Shares.
Appears in 2 contracts
Samples: Sales Agreement (Energy Fuels Inc), Sales Agreement (Energy Fuels Inc)
Status under the Securities Act. The Company was not and is not an ineligible issuer as defined in Rule 405 under the Securities Act Regulations at the times specified in Rules 164 and 433 under the Securities Act Regulations in connection with the offering of the Placement Shares.
Appears in 2 contracts
Samples: Capital on Demand Sales Agreement (Surface Oncology, Inc.), Capital on Demand Sales Agreement (Surface Oncology, Inc.)
Status under the Securities Act. The Company was not and is not an ineligible issuer as defined in Rule 405 under the Securities Act at the times specified in Rules 164 and 433 under the Securities Act in connection with the offering of the Placement Shares. The Company agrees to notify the Agent promptly upon the Company becoming an “ineligible issuer.”
Appears in 1 contract
Samples: Sales Agreement (SITIME Corp)
Status under the Securities Act. The Company was not and is not an ineligible issuer as defined in Rule 405 under the Securities Act at the times specified in Rules 164 and 433 under the Securities Act in connection with the offering of the Placement Shares. The Company is a “foreign private issuer” within the meaning of Rule 405 under the Act.
Appears in 1 contract
Samples: Sales Agreement (Nyxoah SA)
Status under the Securities Act. The Company was not and is not an "ineligible issuer issuer" as defined in Rule 405 under the Securities Act at the times specified in Rules 164 and 433 under the Securities Act in connection with the offering of the Placement Shares.
Appears in 1 contract
Status under the Securities Act. The Company was not not, and is not not, an ineligible issuer as defined in Rule 405 under the Securities Act at the times specified in Rules 164 and 433 under the Securities Act in connection with the offering of the Placement Shares.
Appears in 1 contract
Status under the Securities Act. The Company was not and is not an ineligible issuer as defined in Rule 405 under the Securities Act at the times specified in Rules 164 and 433 under the Securities Act in connection with the offering of the Placement Shares.. 3666640.1
Appears in 1 contract
Status under the Securities Act. The Company was not and is not an ineligible issuer as defined in Rule 405 under the Securities Act at the times specified in Rules 164 and 433 under the Securities Act in connection with the offering of the Placement Shares.
Appears in 1 contract
Samples: Capital on Demand Sales Agreement (Evaxion Biotech a/S)
Status under the Securities Act. The Company was not and is not an ineligible issuer as defined in Rule 405 under the Securities Act at the times specified in Rules 164 and 433 under the Securities Act in connection with the offering of the Placement SharesSecurities.
Appears in 1 contract
Samples: Sales Agreement (Shale Hunter, LLC)
Status under the Securities Act. The Company was not and is not an ineligible issuer as defined in Rule 405 under the Securities Act at the times specified in Rules 164 and 433 under the Securities Act in connection with the offering of the Placement Shares.. 15
Appears in 1 contract
Samples: At Market Issuance Sales Agreement (Parkervision Inc)
Status under the Securities Act. The Company was not and is not an ineligible issuer as defined in Rule 405 under the Securities Act at the times specified in Rules 164 and 433 under the Securities Act in connection with the offering of the Placement Perpetual Preferred Shares.
Appears in 1 contract
Samples: Securities Purchase Agreement (Gorilla Technology Group Inc.)
Status under the Securities Act. The Company was not and is not an “ineligible issuer issuer” as defined in Rule 405 under the Securities Act at the times specified in Rules 164 and 433 under the Securities Act in connection with the offering of the Placement Shares.
Appears in 1 contract
Samples: At Market Issuance Sales Agreement (Midway Gold Corp)
Status under the Securities Act. The Company was not and is not an “ineligible issuer issuer” as defined in Rule 405 under the Securities Act at the times specified in Rules 164 and 433 under the Securities Act in connection with the offering of the Placement Shares.
Appears in 1 contract
Status under the Securities Act. The Company was not and is not an “ineligible issuer issuer” as defined in Rule 405 under the Securities Act at the times specified in Rules 164 and 433 under the Securities Act in connection with the offering of the Placement Shares.
Appears in 1 contract
Status under the Securities Act. The Company was not and is not an “ineligible issuer issuer” as defined in Rule 405 under the Securities Act at the times specified in Rules 164 and 433 under the Securities Act in connection with the offering of the Placement SharesADSs.
Appears in 1 contract
Status under the Securities Act. The Company was not and is not an ineligible issuer as defined in Rule 405 under the Securities Act at the times specified in Rules 164 and 433 under the Securities Act in connection with the offering of the Placement Shares.;
Appears in 1 contract
Status under the Securities Act. The Company was not and is not an ineligible issuer as defined in Rule 405 under the Securities Act at the times specified in Rules 164 and 433 under the Securities Act in connection with the offering of the Placement Preference Shares.
Appears in 1 contract
Samples: Securities Purchase Agreement (Gorilla Technology Group Inc.)
Status under the Securities Act. The Company was not and is not an ineligible issuer as defined in Rule 405 under the Securities Act at the times specified in Rules 164 and 433 under the Securities Act Regulations in connection with the offering of the Placement Shares.
Appears in 1 contract